Lv1
68 积分 2024-08-27 加入
EGFR V834L and L858R Comutation Is Associated With Response to Osimertinib in Non–Small-Cell Lung Cancer
9天前
已完结
Saturation genome editing-based clinical classification of BRCA2 variants
16天前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
23天前
已完结
Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study
5个月前
已完结
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial
5个月前
已完结
Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study
5个月前
已完结
Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway
5个月前
已完结
Functional assessment of all ATM SNVs using prime editing and deep learning
6个月前
已完结
Successful Salvage Treatment With Afatinib and Anti‐PD‐1 Combined Chemotherapy in a Pediatric Patient With Relapsed Cellular‐Type Congenital Mesoblastic Nephroma Harboring an EGFR‐KDD Mutation
8个月前
已完结
Unveiling the BRAF fusion structure variations through DNA and RNA sequencing
10个月前
已完结
皖公网安备34019202002308
